Wiener Privatklinik
Benign prostatic hyperplasia (BPH) treatment cost in Austria typically includes a consultation with a urologist from $200 to $300, while primary surgical options like robotic da Vinci prostatectomy range from $20,000 to $30,000. Total expenses depend on the selected surgical technique, clinic class, and the patient's medical condition. Patients can often find significant savings compared to US private healthcare rates. Top destinations for these procedures include Vienna and Graz.
Typical Benign Prostatic Hyperplasia (BPH) Treatment Costs in Austria
Bookimed Expert Insight: For complex urologic oncology cases, premium university-affiliated centers in Vienna offer the highest value. Wiener Privatklinik provides access to award-winning experts like Professor Georg Shatzl, who leads national prostate workgroups. Patients seeking advanced diagnostics benefit from Leech Private Clinic’s specialized sleep laboratories and MRI facilities. Large-scale centers like Vienna General Hospital (AKH) are best for patients requiring multidisciplinary care across 42 specialized institutes. Döbling Private Hospital is ideal for those prioritizing safety, maintaining complication rates significantly below national averages.
| Turkey | Austria | Spain | |
| Vaporization (with GreenLight Laser) | from $1,800 | from $6,000 | from $3,000 |
| Transurethral microwave therapy (TUMT) | from $2,000 | from $3,500 | from $3,000 |
| Transurethral incision of the prostate (TUIP) | from $2,200 | from $3,500 | from $3,000 |
| Transurethral Water Vapour Ablation | from $2,200 | from $4,000 | from $3,500 |
| Robotic da Vinci prostatectomy | from $17,000 | from $20,000 | from $10,000 |
Dr. Georg Schatzl is a urologist and andrologist. He specializes in men’s health, including erectile dysfunction, infertility, prostate diseases, and urinary tract disorders. He has performed thousands of procedures. Dr. Schatzl is known for his skill in both clinical and surgical urology.
He is an Extraordinary University Professor and a Fellow of the European Board of Urology (FEBU). Dr. Schatzl has published nearly 100 articles in international journals. His work has an impact factor of over 521 and a high h-index. He has given more than 500 presentations at national and international conferences. He also reviews articles for leading urology journals.
Dr. Schatzl has received awards such as the Mauermayerpreis (2003) and the Pfizer Prostate Award (1998). He leads the Prostate Work Group of the Austrian Board of Urology. He also has experience in quality assurance and medical management.